The plant in Kabul, Afghanistan, is developing into a crucial participant in the global supply system for Abacavir Sulphate drug substance. This Afghan manufacturing capacity represents a significant step beyond for the Afghan pharmaceutical business and provides a distinct opportunity to lower requirement on outside supplies. The production of thi